Nuveen Asset Management’s Kinnate Biopharma Inc. Common Stock KNTE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-81,967
| Closed | -$512K | – | 3313 |
|
|
2023
Q1 | $512K | Sell |
81,967
-16,739
| -17% | -$105K | ﹤0.01% | 2798 |
|
|
2022
Q4 | $602K | Sell |
98,706
-12,347
| -11% | -$75.3K | ﹤0.01% | 2833 |
|
|
2022
Q3 | $1.33M | Sell |
111,053
-32
| -0% | -$382 | ﹤0.01% | 2609 |
|
|
2022
Q2 | $1.4M | Buy |
111,085
+19,140
| +21% | +$241K | ﹤0.01% | 2621 |
|
|
2022
Q1 | $925K | Buy |
91,945
+2,069
| +2% | +$20.8K | ﹤0.01% | 2842 |
|
|
2021
Q4 | $1.59M | Sell |
89,876
-5,760
| -6% | -$102K | ﹤0.01% | 2679 |
|
|
2021
Q3 | $2.2M | Buy |
95,636
+37,893
| +66% | +$872K | ﹤0.01% | 2624 |
|
|
2021
Q2 | $1.34M | Buy |
57,743
+8,557
| +17% | +$199K | ﹤0.01% | 2885 |
|
|
2021
Q1 | $1.53M | Buy |
+49,186
| New | +$1.53M | ﹤0.01% | 2732 |
|